Skip to Content
  • Previous Rank
    123
  • Revenues ($M)
    $22,849.00
  • Revenue Percent Change
    -0.6%
  • Profits ($M)
    $1,979.00
  • Profits Percent Change
    -74.4%
  • Assets ($M)
    $79,954.00
  • Employees
    20,800
  • Market Value — as of March 29, 2018 ($M)
    $122,841.50

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in about 100 countries.

Company Info

CEO
Robert A. Bradway
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Thousand Oaks, Calif.
Websitehttp://www.amgen.com
Years on Fortune 500 List19
Employees20,800
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Amgen Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,849.00-0.6%
Profits ($M)$1,979.00-74.4%
Assets ($M)$79,954.00-
Total Stockholder Equity ($M)$25,241.00-
Market Value — as of March 29, 2018 ($M)$122,841.50-

Profit Ratios

Profit as % of Revenues8.7%
Profits as % of Assets2.5%
Profits as % of Stockholder Equity7.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.69
EPS % Change (from 2016)-73.7%
EPS % Change (5 year annual rate)-13.4%
EPS % Change (10 year annual rate)-0.5%

Total Return

Total Return to Investors (2017)22.1%
Total Return to Investors (5 year, annualized)17.6%
Total Return to Investors (10 year, annualized)15.7%